Rockwell Medical stock closes at USD 8.70 near yearly low

Rockwell Medical, Inc. (ISIN US7728001036) closed at USD 8.70 on Nasdaq on September 21, 2026. The price was 38.44 percent below its level 52 weeks earlier, while the 52-week range extended from USD 4.89 to USD 13.30.

Stock remains below yearly midpoint

The September 21 closing price stood USD 4.60 above the 52-week low and USD 4.60 below the 52-week high, placing the stock exactly at the midpoint of its annual range. That symmetry gives the current quote a clear technical reference without implying a directional signal.

Rockwell Medical had a market capitalization of USD 32.51 million as of September 21, 2026. The one-month return was 2.09 percent, contrasting with the 38.44 percent 52-week decline reported for the same date.

Small-cap valuation sets the context

The company develops, manufactures, commercializes and distributes hemodialysis products for dialysis providers worldwide. Its market capitalization of USD 32.51 million as of September 21, 2026 places the stock in the small-cap segment, where changes in operating results can have an outsized effect on valuation.

The numerical contrast is the key signal: a 2.09 percent one-month gain against a 38.44 percent annual loss. The comparison describes the recent trading path, but it does not establish a forecast for the next reporting period.

USD 8.70 remains the closing reference

Rockwell Medical stock closed at USD 8.70 on Nasdaq on September 21, 2026. The same dated market snapshot placed the 52-week low at USD 4.89, the 52-week high at USD 13.30 and market capitalization at USD 32.51 million.

More news and analyses on Rockwell Medical stock